Healthcare Industry News: endoscopic
News Release - July 2, 2008
Visionsense Announces Food and Drug Administration (FDA) 510(k) Clearance for Neurosurgery
VSII -- Visionsense Stereoscopic Vision SystemORANGEBURG, N.Y., July 2, 2008 (Healthcare Sales & Marketing Network) -- Visionsense Corp. announces FDA 510(k) Clearance of the new VSII -- Visionsense Stereoscopic Vision System for use in MIS Neurosurgery.
The ``Miniature Microscope,'' a 3.4 mm 3D camera is used in Tran-nasal skull-base and other minimally invasive Neurosurgical procedures, providing a local stereoscopic view of the anatomy.
``This system provides a revolutionary approach to Neurosurgery, allowing the surgeon a stereoscopic operating microscope view in endoscopic sizes, benefiting patients by converting craniotomies to minimal invasive surgery,'' says the CEO, Avi Yaron.
The company plans to launch the VSII system late 2008.
About Visionsense Corp.
Visionsense exclusively licenses its technology, application or segment specific, to strategic partners, benefiting a unique competitive advantage. The Company develops and manufactures customized Miniature Stereoscopic 3D cameras/sensors that enable surgeons to see natural-like Stereovision, thus enhancing image understanding and hand-eye coordination. These re-useable or disposable cameras are distally assembled on the tip of a flexible / rigid scope or instrument. The technology further assists the surgeon by providing advanced software features, such as image fusion (combining stereovision with MRI, CT or ultrasound for real-time ``see-through-tissue'') and 3D measurements.
Source: Visionsense
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
